1960
DOI: 10.1056/nejm196007142630204
|View full text |Cite
|
Sign up to set email alerts
|

The Significance ofCandida albicansin Human Sputum

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
25
0
1

Year Published

1962
1962
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(26 citation statements)
references
References 29 publications
0
25
0
1
Order By: Relevance
“…Because there is no pathognomonic clinical picture for Candida pneumonia, diagnosis has relied for years on detecting the presence of Candida in sputum or bronchoscopic specimens. However, each of these methods is subject to error since Candida is a normal inhabitant of the mouth, and can be recovered from sputum in 20 to 55% of normal subjects (21). In our study, only two patients with positive Candida cultures from lung biopsies had true Candida lung infection.…”
Section: Discussionmentioning
confidence: 57%
“…Because there is no pathognomonic clinical picture for Candida pneumonia, diagnosis has relied for years on detecting the presence of Candida in sputum or bronchoscopic specimens. However, each of these methods is subject to error since Candida is a normal inhabitant of the mouth, and can be recovered from sputum in 20 to 55% of normal subjects (21). In our study, only two patients with positive Candida cultures from lung biopsies had true Candida lung infection.…”
Section: Discussionmentioning
confidence: 57%
“…Nothing is to be seen for the first 24 hours, though an occasional subject com¬ plained of slight itching. In 36 to 72 hours, tiny, discrete papules emerge on an erythematous background.…”
Section: Evolution Of Lesionsmentioning
confidence: 99%
“…A cândida representa parte da flora normal, sendo cultivado a partir da cavidade oral em 7% da população 11 . O tratamento da laringite fúngica constitui-se no uso de anti-fúngicos sistêmicos, embora alguns autores considerem, para pacientes imunocompetentes, uma terapia inicial com agentes tópicos como a nistatina por período mínimo de três semanas antes do uso dos agentes sistêmicos.…”
Section: Discussionunclassified